ARON 3D_Transparent

Publications

All our publications
Sex ARON 2

Sex as modifier of survival in patients with advanced urothelial cancer treated with pembrolizumab

Incorvaia L,
et al. Sci Rep.
2025
Obesity ARON 1

Clinico-Pathological Features Influencing the Prognostic Role of Body Mass Index in Patients With Advanced Renal Cell Carcinoma Treated by Immuno-Oncology Combinations (ARON-1)

Santoni M
et al. Clin Genitourin Cancer
2023
0 3 1

First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study

Roviello
Roviello et al. Cancer Immunol Immunother
2025
09

Impact of time-of-day administration of immunotherapy on survival in metastatic renal cellcarcinoma: the MOUSEION-09 meta-analysis

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
0 3

Metastatic sites and clinical outcomes in renal cell carcinoma patients receiving immune-based combinations: the MOUSEION-08 study

Alessandro Rizzo
et al. Clin Exp Metastasis
2024
MOUSEION 07

Sex differences in adverse events among cancer patients receiving immune checkpointinhibitors: the MOUSEION-07 systematic review and meta-analysis

Elsa Vitale
Elsa Vitale et al. Sci Rep
2024

Do you want to join us ?

Join us today
ARON 3D_Transparent
Youtube Linkedin

Coordinated and designed by Atteggiamento Digitale .

Legal and Privacy.